Abstract:Classical swine fever virus (CSFV) is a major animal pathogen threatening the global pork industry. To date, numerous anti-CSFV monoclonal antibodies (mAbs) and their recognizing epitopes have been reported. However, few mAbs were systematically characterized for the capacity to differentiate field CSFV isolates from CSF vaccine strains, and the molecular basis associated with antigenic differences between vaccines and field isolates is still largely unknown. In the present study, recombinant CSFV structural glycoproteins E2 of both virulent and vaccine strains and E rns of vaccine strain were expressed using eukaryotic cells and murine mAbs generated against E2 and E rns . After serial screening and cloning of the hybridomas, the viral spectra of mAbs were respectively determined by indirect fluorescent antibody assay (IFA) using 108 CSFVs, followed by Western blot analysis using expressed glycoproteins of all CSFV sub-genotypes including vaccine strains. The antigenic structures recognized by these mAbs were characterized by epitope mapping using truncated, chimeric, and site-directed mutated E2 and E rns proteins. We have identified two vaccine-specific, one field isolate-specific, and two universal CSFV-specific mAbs and five novel conformational epitopes with critical amino acid (aa) motifs that are associated with these five mAbs: 213 EPD 215 , 271 RXGP 274 , and 37 LXLNDG 42 on E2 and 38 CKGVP 42 , W 81 , and D 100 /V 107 on E rns . Particularly, E 213 of E2 is field isolate-specific, while N 40 of E2 and D 100 /V 107 of E rns are vaccine strain-specific. Results from our study further indicate that N 40 D of E2 mutation in field strains was likely produced under positive selection associated with long-term mass vaccination, leading to CSFV evasion of host immune response. Taking together, this study provides new insights into the antigenic structure of CSFV E2 and E rns and the differentiating mAbs will contribute to the development of a diagnostic strategy to differentiate C-strain vaccination from natural infection (DIVA) of CSFV in terms of elimination of CSF in China.

Characterization of specific antibodies and the establishment of sandwich ELISA and ELISPOT systems for swine IL-4

Development and Characterization of New Monoclonal Antibodies Against Porcine Interleukin-17A and Interferon-Gamma

K205R specific nanobody-horseradish peroxidase fusions as reagents of competitive ELISA to detect African swine fever virus serum antibodies

Preparation of the Monoclonal Antibody Against Swine IgG

Preparation and characterization of monoclonal antibodies recognizing two CD4 isotypes of Microminipigs

Identification and primary application of hybridomas cell secreting monoclonal antibodies against mink (Neovison vison) interferon-gamma

Development Of A Sensitive Monoclonal Antibody-Based Elisa For The Determination Of A Beta-Adrenergic Agonist Brombuterol In Swine Meat, Liver And Feed Samples

Production And Characterization Of Monoclonal Antibodies To (Poly100)S1 Protein Of Avian Infectious Bronchitis Virus

Development of a Blocking ELISA for Detection of Mycoplasma Hyopneumoniae Infection Based on a Monoclonal Antibody Against Protein P65.

Characterization of monoclonal antibodies that specifically differentiate field isolates from vaccine strains of classical swine fever virus

Preparation of Monoclonal Antibodies Against Recombinant Bovine IFN-gamma and Development of Sandwich ELISA for Bovine IFN-gamma Detection

Characterization of Monoclonal Antibodies Against Ha Protein of H1n1 Swine Influenza Virus and Protective Efficacy Against H1 Viruses in Mice

Development of a Competitive Enzyme-Linked Immunosorbent Assay Targeting the-p30 Protein for Detection of Antibodies against African Swine Fever Virus

Development and Validation of an Enzyme-Linked Immunosorbent Assay for the Quantification of a Recombinant Humanized Anti-Il-4rα Monoclonal Antibody CM310 in Serum and Its Application to Pharmacokinetic Study in Sprague-Dawley Rats.

Generation and Application of Monoclonal Antibodies against Porcine S100A8, S100A9, and S100A12 Proteins Using Hybridoma Technology

Development of a Blocking Immunoperoxidase Monolayer Assay for Differentiation Between Pseudorabies Virus-Infected and Vaccinated Animalss

Development of an indirect ELISA for the immunoprotection evaluation of E2 antibodies against classical swine fever virus

Establishment and characterization of a novel indirect ELISA method based on ASFV antigenic epitope-associated recombinant protein

Production and Characterization of Monoclonal Antibody to Duck IL-2

Antigen-Specific Single B Cell Sorting and Monoclonal Antibody Cloning in Guinea Pigs

Development and Characterization of Monoclonal Antibody Against GP5 Protein of Porcine Reproduction and Respiratory Syndrome Virus